Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant in Delayed Sleep Phase Syndrome
NCT06874855Phase 4Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Mar 2023
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in delayed sleep phase syndrome (DSPS) comparing Placebo with Lemborexant (2 arms). Primary endpoint: Change in actigraphy sleep latency onset at 4 weeks. Started Mar 2023; status: recruiting.
02
Drugs
lemborexant
03
Conditions
delayed sleep phase syndrome (DSPS)
Beyond the preview
Go deeper on NCT06874855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06874855.